An interventional study of Prayer in Depressive Symptoms, Anxiety Symptoms and Pain, sponsored by Patricia Kaufman. Completed at 1 site in United States. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by Patricia Kaufman · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 3,715 studies in Depression with a site in United States — 582 open to participants now, 720 under way, 30 of them phase 3. Depression · United States.
Among the 3,715 studies in Depression with a site in United States, this one is the 3,081st largest by enrollment of the 3,322 interventional ones that give a count, is one of 208 that started in 2025, is one of 2,221 with no phase, and was the 3,715th registered.
8,595 studies on the registry are indexed under Depression; 1,732 are open to participants now.
Browse Depression studies →582 of the 3,715 studies in Depression with a site in United States are open now. Recruiting first, the newest first:
Medical University of South Carolina · Sites in United States
Ages 18–70
Children's Mercy Hospital Kansas City · Sites in United States
Ages 13–17
NeuroRx, Inc. · Sites in United States
Ages 18–80
University of Michigan · Sites in United States
Ages 13+ · Healthy volunteers
Ohio State University · Sites in United States
Ages 21–65
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 1,094 Depression studies recruiting now, 472 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 314 take healthy volunteers.
This study: 18 Years to 85 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
3,715 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 235 · Phase 2 441 · Phase 3 285 · Phase 4 265
First in 1977; this study’s year is marked. 208 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 8 is below the median of 81 across 7,078 interventional studies indexed under Depression.
Median enrollment 72 across the 3,322 interventional studies, 138 across the 371 observational. Of the 2,764 that completed or were terminated, 1,045 (38%) have results posted.
This tab as a report to print or save as PDF → With an account.
392 of 3,715 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Patricia Kaufman as lead sponsor.
Patricia Kaufman has 1 study filed under Depression — fewer than ten, so there is no comparison to draw.
300 of the studies in Depression with a site in United States that are under way reach primary completion within a year, 12 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05552053Phase 3Cedars-Sinai Medical CenterResources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women | 2026-12-31 |
| NCT06922110Phase 3Xenon Pharmaceuticals Inc.An Open-Label Study of Azetukalner in Major Depressive Disorder | 2027-01 |
| NCT05474846Phase 3M.D. Anderson Cancer CenterCombination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer | 2027-02-28 |
| NCT04777357Phase 3AbbVieA Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder. | 2027-03 |
| NCT07076407Phase 3Xenon Pharmaceuticals Inc.A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3) | 2027-05 |
Add all 300 to your calendar (.ics) → With an account.
Among the 3,715 studies in Depression with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to evaluate the effects of prayer on cancer cases. This research project will focus on the effects of prayer on adults diagnosed with cancer. Participation in this research project is voluntary. It will involve 4 weeks of practicing prayer as a therapeutic intervention, once per day at the same time each day for 15 minutes. It will also include completing surveys at the start of the study and then once a week, which will take approximately 20 minutes in total to complete. The surveys will also be administered over the 4-week time period. Both the prayer intervention and surveys will be self-conducted. These surveys will ask questions about emotional, psychological, physical, and spiritual health.
The purpose of this pilot study is to examine the feasibility and preliminary effects of a structured 4-week prayer intervention on anxiety, depression, pain, spiritual health, and quality of life in adults diagnosed with cancer. The primary research question guiding this study is whether participation in a structured prayer intervention could improve psychological distress, spiritual well-being, pain, and overall quality of life among adults with cancer. It is hypothesized that participation in the intervention would be associated with reductions in anxiety, depression, and pain, as well as improvements in spiritual health and overall quality of life.
Inclusion Criteria: current or prior cancer diagnosis, including active disease, recurrent disease, partial remission, or complete remission. Participants were required to be willing to pray daily for at least 15 minutes over a 4-week period and to complete weekly online questionnaires throughout the study. Additional inclusion criteria included the ability to read and write English, provide independently, have access to reliable internet service, and complete online surveys independently. No prior religious affiliation, spiritual practice, or established prayer habits were required for participation. Participants already engaged in prayer prior to enrollment were not excluded from the study.
Exclusion Criteria: if they were younger than 18 years of age, unable to provide informed consent independently, unable to complete online questionnaires in English, or unable to reliably participate in the 4-week intervention and survey schedule.
-
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants engaged in approximately 15 minutes of self-directed prayer daily for 4 weeks. Prayer guidelines were provided.
Other: Prayer
15 minutes of self-directed prayer daily for 4 weeks
PHQ-9 depression score
PHQ-9 (depression score) mean change from baseline to 4 weeks
Time frame: 4 weeks
Anxiety scores (GAD-7)
Anxiety scores (GAD-7) mean change from baseline to 4 weeks
Time frame: 4 weeks
Pain scores (GCPS-R)
Pain scores (GCPS-R) mean change from baseline to 4 weeks
Time frame: 4 weeks
Quality of life scores (FACT-G7)
Quality of life scores (FACT-G7) mean change from baseline to 4 weeks
Time frame: 4 weeks
Spiritual well-being scores (FACIT-Sp-12)
Spiritual well-being scores (FACIT-Sp-12) mean change from baseline to 4 weeks
Time frame: 4 weeks
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Nov 2025 to primary completion in Mar 2026, 4 months.
Of 3,479 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's 4 months is below that.
Counting every sponsor, half of 3,577 studies reached it within 21 months; a quarter within 9 and three quarters within 41.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.